H.L. Atkins

Radiopharmaceuticals XXVII. 18F-labeled 2-deoxy-2-fluoro-d-glucose as a radiopharmaceutical for measuring regional myocardial glucose metabolism in vivo: tissue distribution and imaging studies in animals.

Brian M. Gallagher, A.N. Ansari, H.L. Atkins et al. · Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) · 1977 · 205 citations

Treatment of metastatic bone pain with tin-117m Stannic diethylenetriaminepentaacetic acid: a phase I/II clinical study.

S.C. Srivastava, H.L. Atkins, Gerbail T. Krishnamurthy et al. · PubMed · 1998 · 92 citations

Pain Therapy, Pain Medicine, Pharmacotherapy +20

Biodistribution of Sn-117m(4+)DTPA for palliative therapy of painful osseous metastases.

H.L. Atkins, L.F. Mausner, S.C. Srivastava et al. · Radiology · 1993 · 63 citations

Painful Osseous Metastases, Clinical Therapeutic Trial, Pathology +17

Conduct of a controlled clinical trial.

H.L. Atkins · BMJ · 1966 · 57 citations · Full text

Family Medicine, Controlled Clinical Trial, Clinical Trial Analysis +9

Organic radiopharmaceuticals labeled with isotopes of short half-life. V. 18 F-labeled 5- and 6-fluorotryptophan.

H.L. Atkins, David R. Christman, J.S. Fowler et al. · PubMed · 1972 · 53 citations

Short Half-life, Organic Geochemistry, Bioorganic Chemistry +10